What does the evidence say about Cocoa Products Metabolic Syndrome Meta-Analysis?

The current Migaku evidence database contains 1 reusable source document for Cocoa Products Metabolic Syndrome Meta-Analysis. This answer focuses on benefits, uncertainty, and practical interpretation. - The meta-analysis showed a significant effect of cocoa supplementation on triacylglycerol levels (-0.21 mmol/L, 95% CI: -0.40, -0.02; p = 0.0333), and subgroup analysis suggested that cholesterol levels were reduced with cocoa supplementation in patients with dyslipidemia and diabetes. [Gomes Chagas A (2026); evidence level 1] - Our study suggests that cocoa intake has limited evidence of benefit, mainly for triglycerides, furthermore, effects and that the duration, type, and clinical status of patients were important determinants for favorable effects on biomarkers related to metabolic syndrome. [Gomes Chagas A (2026); evidence level 1] - Cocoa supplementation has been shown to improve parameters related to metabolic syndrome, although results have been contradictory. [Gomes Chagas A (2026); evidence level 1] - We conducted a systematic review and meta-analysis to examine the effect of cocoa products on lipid and glycemic profiles, blood pressure levels, and anthropometric measurements in individuals with metabolic syndrome and related diseases. [Gomes Chagas A (2026); evidence level 1] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.